chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 23.0
Sex: F
Vaccine: COVID19
Symptoms: Peripheral swelling, Pruritus, Rash macular, Swelling
Clinical narrative: After about 10 days of getting the first shot of MODERNA COVID19 vaccine, I began to feel itchy on my feet starting the night before. Waking up, my feet felt unusually itchy and I checked to see that my feet were swollen with red spots. After half an hour, I began to feel itchy on my elbows and found that there are some swollen spots as well. At first I thought I was bitten by ants or bed bugs but throughout the day, hour after hour, I noticed that there are more red spots arising. Now I have these red spots scattered over the palms of both of my feet, on both sides of my hands, and all over my elbows. They feel itchy and swell larger if I touch them or scratch (accidentally).
Age: 23.0
Sex: F
Vaccine: COVID19
Symptoms: Aphthous ulcer, Mouth ulceration, Myalgia, Pain in extremity
Clinical narrative: Arm soreness starting a few hours after vaccination and lasting for 24-36 hours; mild-moderate pain Muscle aches starting 12 hours after vaccination and resolving within 24 hours Mouth Ulcers-48 hours following the vaccine painful mouth ulcers/canker sores appeared. 14 were counted all appearing suddenly on gums , inside of lips, and tongue. Ulcers have not yet healed
Sex: F
Vaccine: COVID19
Symptoms: Rash
Clinical narrative: Her mother noticed a rash forming all over her body; This is a spontaneous report from a contactable reporter (Patient daughter). A 83-year-old-female patient (reporter mother) received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, lot number and expiry dates were not provided), via an unspecified route of administration, on 20Mar2021, as a single dose for COVID-19 immunisation. Patient medical history and concomitant medications were not reported. It was reported that patient received the second dose of the Pfizer BioNTech COVID-19 vaccine on 20Mar2021 and Yesterday the patient noticed a rash forming all over her body and she would like to know if it is possible that this could be related to the vaccine, even though it has been nearly 4 weeks since she got the dose. Outcome of the event was unknown.   No Follow-up attempts are needed. Information about lot/batch number cannot be obtained.
Age: 57.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Chest discomfort, Chills, Discomfort, Headache, Oropharyngeal discomfort
Clinical narrative: 24 hours later after the second vaccine I began to feel tightness in my chest and my throat that felt similar to GERD. Simultaneously I got the chills and had tingling in my head with a slight headache. I had to go to bed because I didn't know what to do so I took a atarax and protonix. 707 p.m. same day felt a little better in terms of the throat tightening but still feeling the same sensations very uncomfortable.
Age: 57.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Paraesthesia
Clinical narrative: 24 hours later after the second vaccine I began to feel tightness in my chest and my throat that felt similar to GERD. Simultaneously I got the chills and had tingling in my head with a slight headache. I had to go to bed because I didn't know what to do so I took a atarax and protonix. 707 p.m. same day felt a little better in terms of the throat tightening but still feeling the same sensations very uncomfortable.
Age: 51.0
Sex: M
Vaccine: COVID19
Symptoms: Computerised tomogram, Diplopia, Inflammation, Magnetic resonance imaging, Ocular discomfort
Clinical narrative: 04/05/2021 - Inflamation in neck and shoulders. 04/06 to 04/09/2021 - Began experiencing double vision and felt pressure behind right eye. Slept nearly all day during this time frame. 04/12/2021 (12:20pm) - Phone appointment with primary care doctor to discuss symptoms experienced after receiving Pfizer vaccine. Office vist scheduled for 04/22/2021. 04/22/2021 (11:50am) - Office visit to Dr. Continued to experience double vision and pressure behind right eye in the interim. Referred to opthamologist and ordered MRI. 04/27/2021 (3:15pm) - Office visit to Dr. No evidence of detatched retina, eye pressure normal. Agreed that MRI needed.
Age: 51.0
Sex: M
Vaccine: COVID19
Symptoms: Somnolence
Clinical narrative: 04/05/2021 - Inflamation in neck and shoulders. 04/06 to 04/09/2021 - Began experiencing double vision and felt pressure behind right eye. Slept nearly all day during this time frame. 04/12/2021 (12:20pm) - Phone appointment with primary care doctor to discuss symptoms experienced after receiving Pfizer vaccine. Office vist scheduled for 04/22/2021. 04/22/2021 (11:50am) - Office visit to Dr. Continued to experience double vision and pressure behind right eye in the interim. Referred to opthamologist and ordered MRI. 04/27/2021 (3:15pm) - Office visit to Dr. No evidence of detatched retina, eye pressure normal. Agreed that MRI needed.
Age: 36.0
Sex: F
Vaccine: COVID19
Symptoms: Injection site rash, Rash erythematous, Rash macular, Skin indentation, Skin warm
Clinical narrative: A blotchy red rash appeared on my left upper arm at the injection site and outward one week after the first dose. The arm feels warm and dimply. NO other symptoms.
Sex: F
Vaccine: COVID19
Symptoms: Cyanosis, Hypersensitivity, Peripheral swelling, Urticaria
Clinical narrative: her hand swelled so bad she had to have her ring cut off and her ring finger turned purple; her hand swelled so bad she had to have her ring cut off and her ring finger turned purple; her allergist says take this or that allergy pill; has a hive the size of her hand on the inside of her thigh/the hives are on her entire body: face, ers, throat, nec ,torso, arms and legs, arm pits, buttocks, between her toes , in her hair; This is a spontaneous report from a contactable consumer or other non hcp (Patient).  A female patient of 63-Year-old received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: Solution for injection, lot number: Unknown) dose 1 via an unspecified route of administration on 18Jan2021 as single dose, dose 2 via an unspecified route of administration on 8Feb2021 as single dose, for covid-19 immunization.  The patient medical history and concomitant medications were not reported. Patient stated that the hives started five days after the first dose on 23Jan2021 and she had suffered with hives the entire time. She had a hive the size of her hand on the inside of her thigh. Patient reported the hives were on her entire body: face, ears, throat, neck, torso, arms and legs, arm pits, buttocks, between her toes, in her hair. She further told that her hand swelled so bad that she had to have her ring cut off and her ring finger turned purple. Her allergist told take this or that allergy pill. Caller stated her allergist, internist and dermatologist could not do anything. Patient stated that the only thing that made them go away was a solu medrol shot but they would not go away. Patient stated she had two bad days after the second shot that she should have gone to the emergency room, but she did not go. Patient told that the only new thing was the covid 19 shot. Patient wanted to know what people do. Patient wanted to know if Pfizer had done research with these hives. Caller stated she spoke to (Name)and reported on VAER. The outcome of the events was reported as an unknown.   No follow-up attempts are needed; information about lot/batch number cannot be obtained
Age: 70.0
Sex: F
Vaccine: COVID19
Symptoms: Cough, Nasal congestion, Rhinorrhoea
Clinical narrative: runny nose; cough; congestion; This is a spontaneous report from a contactable consumer (Patient, self-reported).   A 70-years-old female patient received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Solution for injection, Batch/Lot number was not reported), via an unspecified route of administration on an unspecified date as SINGLE DOSE for covid-19 immunisation. The patient medical history was not reported. The patient's concomitant medications were not reported. On an unspecified date, the patient experienced runny nose, cough and congestion. The clinical outcome of the events was unknown.   No follow-up attempts are needed; information about lot/batch number cannot be obtained.
Sex: F
Vaccine: COVID19
Symptoms: Nausea, Pain in extremity
Clinical narrative: She explained both of their "arms are sore"; she was "nauseous" this morning.; This is a spontaneous report from a contactable consumer. A 41-year-old female consumer (patient) reported for herself that she received her first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Solution for injection, Batch/Lot number: unknown, Expiration date: Not reported) via an unspecified route of administration on an unspecified date as single dose for COVID-19 immunisation. The patient medical history and concomitant medications were not reported. On an unspecified date, the patient reported that she herself and her 50-year-old husband received their first dose of the vaccine the day before at a drive-through. She explained that both of their arms were sore and she was nauseous that morning. She also said the pain was killing her. She asked if it's true that pain medication cannot be taken post-vaccination. Outcome was unknown for all the events.    No follow-up attempts are needed; information about lot/batch number cannot be obtained.
Age: 45.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, SARS-CoV-2 test, Vaccination failure
Clinical narrative: Positive for Covid on19Apr2021. Exposure to confirmed positive in home; Positive for Covid on 19Apr2021. Exposure to confirmed positive in home; This is a spontaneous report from a contactable other healthcare professional. A 45-years-old non-pregnant female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, formulation: solution for injection), dose 1 intramuscular in right arm on 19Jan2021 at 13:45 (Batch/Lot Number: EL3247) and dose 2 via an unspecified route of administration on 10Feb2021 (Batch/Lot Number: EL3247), both as single dose for COVID-19 immunization (at the age 45-years-old). The patient's medical history and concomitant medications. Patient did not receive any other vaccines within 4 weeks. Prior to vaccination, the patient was not diagnosed with COVID-19. On 19Apr2021, the patient experienced positive for COVID, exposure to confirmed positive in home. The  patient had symptoms, stuffiness and sore throat which started on 18Apr2021. On 17Apr2021, patient underwent lab tests and procedures which included sars-cov-2 test: positive. Outcome of the event was unknown.; Sender's Comments: Based on the information currently available, lack of efficacy of the suspected vaccine BNT162B2 cannot be completely excluded. However, the efficacy of a vaccine varies from person to person and depends on various other factors.
Sex: F
Vaccine: COVID19
Symptoms: Aphonia, Cough, Headache, Oropharyngeal pain
Clinical narrative: she has developed a sore throat; coughing; headache; lost voice; This is a spontaneous report from a contactable consumer(patient) via medical information team. A 61-year-old female patient received second dose of BNT162B2(PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration on 11Apr2021 at a single dose for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. Historical vaccine included first dose of BNT162B2(PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration on 11Apr2021 at a single dose for COVID-19 immunization. The patient developed a sore throat, coughing, headache and lost voice on 19Apr2021. The outcome of the event was unknown.  No follow-up attempts are needed; information about lot/batch number cannot be obtained.
Sex: F
Vaccine: COVID19
Symptoms: Arthropathy, Dizziness
Clinical narrative: Slight dizziness/I am now dizzy when I lay down; Knees getting weak; This is a spontaneous report from a contactable consumer (patient) via medical information team. A 61-years-old female patient receive second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE, Solution for injection, lot number and expiration date were not reported), via an unspecified route of administration on 08Apr2021 as single dose for covid-19 immunisation. The patients medical history and concomitant medications were not reported. Reportedly, on an unknown date patient took historical vaccine dose 1 BNT162B2 for COVID-19 immunisation. The patient reported that I am concerned because I didnt have any problem with either dose until the 18Apr2021, had slight dizziness and knees getting weak and it gets worse everyday. I am now dizzy when I lay down. Patient asked what should I do next. No PQC was present. The outcome of the events was unknown.  No follow-up attempts are needed; information about lot/batch number cannot be obtained.
Sex: M
Vaccine: COVID19
Symptoms: Muscle strain, Pain in extremity
Clinical narrative: my arm was sore and now it has progressed into my underarm; It's almost like a pulled muscle like a tendon is pulled and contracted. I tried to pull myself up and it pull the muscle.; This is a spontaneous report from a contactable consumer. A male patient of unspecified age received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE) (formulation: Solution for injection), (lot number/Expiry date: not reported) via unspecified route of administration on unspecified date as single dose for COVID-19 Immunization. Patient medical history and concomitant medications were not reported. Patient experienced at first his arm was sore and now it had progressed into my underarm. It was almost liked a pulled muscle like a tendon was pulled and contracted. I tried to pull myself up and it pull the muscle on unspecified date. The outcome of event was unknown.  No follow-up attempts are needed; information about lot/batch number cannot be obtained.
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site erythema, Vaccination site irritation, Vaccination site pruritus, Vaccination site swelling
Clinical narrative: the injection site has started to become red; injection site has started to become irritated,; injection site has started to become red, irritated, itchy/minor itching; injection site was swollen; This is a spontaneous report from a contactable consumer (patient) via Medical information team. A 52-year-old female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, Lot number: unknown), via an unspecified route of administration as a single dose on 11Apr2021 for covid 19 immunization. The patient medical history and concomitant medications were not reported. On 20Apr2021, 9 days after first dose, the injection site has started to become red, irritated, itchy, and swollen. She noted that 2 days after the vaccine was given, the injection site was swollen but not red and there was some minor itching, but the caller was concerned that the symptoms mainly started 9 days after the dose of the vaccine. The patient enquired whether this is normal or has this been reported before. The outcome of the events was unknown.  No follow-up attempts are needed; information about lot/batch number cannot be obtained.
Sex: F
Vaccine: COVID19
Symptoms: Panic attack, Peripheral coldness, Tremor
Clinical narrative: panic attack; shaky hands right after taking the 2nd dose.; Cold hands; This is a spontaneous report received from a contactable consumer (patient) from a Pfizer sponsored program . A female patient of an unspecified age received second dose of BNT162B2 (Solution for injection, PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) an unspecified route of administration on 17Apr2021 as single dose for covid-19 immunisation. The patient's medical history and concomitant medications were not reported. Patient historical vaccine included first dose of BNT162B2 (Solution for injection, PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) an unspecified route of administration on 27Mar2021 as single dose for covid-19 immunisation. On 17Apr2021, the patient experienced a panic attack, cold and shaky hands right after taking the 2nd dose. Patient asked whether she needs to seek assistance due to the symptoms experienced. The outcome of the events was unknown.  No follow-up attempts possible. No further information expected.
Age: 22.0
Sex: F
Vaccine: COVID19
Symptoms: Deafness unilateral, Tinnitus
Clinical narrative: This is a spontaneous report from a non-contactable consumer (patient). A 22-year-old female patient received bnt162b2 (COVID 19 Pfizer), dose 1 via an unspecified route of administration, administered in right arm on 14Apr2021 15:00 (lot unknown, reason: misplaced/discarded) as single dose for COVID -19 immunization. Medical history included known allergies: penicillin. The patient's concomitant medications were not reported. The patient experienced complete loss of hearing in left ear. White noise sound only. Less than 24 hours after administration on 15Apr2021 with outcome of unknown. The patient is not pregnant. No treatment was given for events. The patient has not received other vaccine in four weeks. The patient was not diagnosed with covid prior vaccination has not been tested for covid post vaccination.  No follow-up attempts are possible. Information about lot/batch number cannot be obtained.
Sex: M
Vaccine: COVID19
Symptoms: Leukaemia, SARS-CoV-2 antibody test
Clinical narrative: This is a spontaneous report from a Pfizer Sponsored Program. A contactable consumer reported that a male patient of an unspecified age received bnt162b2 (BNT162B2), via an unspecified route of administration on an unspecified date (Batch/Lot number was not reported) as single dose for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. The patient did not have antibodies after getting tested. Has leukaemia on an unspecified date. The patient underwent lab tests and procedures which included SARS-CoV-2 antibody test: negative on an unspecified date.  The outcome of the event was unknown. The event was considered as serious (medically significant).  Information on the lot/batch number has been requested.
Sex: M
Vaccine: COVID19
Symptoms: Dizziness
Clinical narrative: Dizzy; This is a spontaneous report from a contactable consumer (patient's son) via Pfizer sponsored program. A male patient of an unspecified age received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; lot number and expiration date were not reported), via an unspecified route of administration on an unspecified date at single dose for COVID-19 immunization. The patient's medical history and concomitant medication were not reported. The patient got dizzy after the first dose on an unspecified date. The patient wanted to know if he has to have a second dose and where to schedule. The outcome of the event was unknown.  No follow-up attempts are possible; Information about lot/batch number cannot be obtained.
Sex: M
Vaccine: COVID19
Symptoms: Pain in extremity, Peripheral swelling, Ultrasound Doppler
Clinical narrative: swelling in arm; have swelling in arm and pain; This is a spontaneous report from a contactable consumer reporting himself. A 90-years-old male patient received bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, solution for injection), dose 2 via an unspecified route of administration on 03Feb2021 (Batch/Lot number was not reported) as single dose for covid-19 immunization. The patient's medical history and concomitant medications were not reported. The reporter stated that, he received the Pfizer covid vaccine second dose 03Feb2021. He has been seen a doctor twice and had his arm dopplered. Approximately on an unknown date in 2021, the patient had swelling in arm and pain. Also reported that, first time I went he felt my whole arm with his fingers and said no blood clot. Then he went to another doctor, they wanted a doppler and they said he had no blood clot after doppler on an unknown date in 2021, it was negative. They put him on prednisone 10mg twice a day for 5 days and it didn't help. The doctor told me the pain may last 2 to 3 months more. The patient wanted to know that he is going to have put up with this for that long or more. He stated that, I saw the doctor last Wednesday. He wanted to be reassured that he knows what he is talking about. As he is 90 and can't take a shower on his own, and the girl that helps told him that his arm is still swollen. The outcome of the event pain was unknown, and the patient did not recover from the swelling at the time of report. NO PQC present.   No Follow-up attempts are needed; information about lot/batch number cannot be obtained.
Age: 62.0
Sex: F
Vaccine: COVID19
Symptoms: Bronchial oedema, Dizziness, Feeling abnormal, Malaise, Nasal oedema
Clinical narrative: My nasal passages, throat, and bronchial tubes started to swell up; feeling faint; general malaise; My nasal passages, throat, and bronchial tubes started to swell up; My nasal passages, throat, and bronchial tubes started to swell up; brain fog; This is a spontaneous report from a non-contactable consumer (patient).  A 62-years-old female patient (not pregnant) received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), dose 2 via an unspecified route of administration, administered in arm left on 08Apr2021 14:00 (Batch/Lot Number: ER8729) (at the age of 62-years-old) as single dose for covid-19 immunization.  Medical history included known allergies: penicillin from an unknown date. The patient's concomitant medications were not reported. Historical Vaccine included BNT162B2, dose 1, administered in arm left on 18Mar2021 01:45 P.M. (Batch/Lot Number: ER2613) (at the age of 62-years-old) for covid-19 immunization. The patient did not get COVID prior vaccination and did not receive COVID test post vaccination. About five minutes (as reported) after the patient received the shot, she started feeling faint on 08Apr2021 02:15 P.M. Her nasal passages, throat, and bronchial tubes started to swell up on 08Apr2021 02:15 P.M. Taking a decongestant when she got home helped that. For a few days she had congestion and brain fog along with general malaise. Treatment received included she took decongestants. The outcome of the events was resolved in Apr2021.  No follow-up attempts are possible. No further information is expected.
Age: 62.0
Sex: F
Vaccine: COVID19
Symptoms: Pharyngeal swelling
Clinical narrative: My nasal passages, throat, and bronchial tubes started to swell up; feeling faint; general malaise; My nasal passages, throat, and bronchial tubes started to swell up; My nasal passages, throat, and bronchial tubes started to swell up; brain fog; This is a spontaneous report from a non-contactable consumer (patient).  A 62-years-old female patient (not pregnant) received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), dose 2 via an unspecified route of administration, administered in arm left on 08Apr2021 14:00 (Batch/Lot Number: ER8729) (at the age of 62-years-old) as single dose for covid-19 immunization.  Medical history included known allergies: penicillin from an unknown date. The patient's concomitant medications were not reported. Historical Vaccine included BNT162B2, dose 1, administered in arm left on 18Mar2021 01:45 P.M. (Batch/Lot Number: ER2613) (at the age of 62-years-old) for covid-19 immunization. The patient did not get COVID prior vaccination and did not receive COVID test post vaccination. About five minutes (as reported) after the patient received the shot, she started feeling faint on 08Apr2021 02:15 P.M. Her nasal passages, throat, and bronchial tubes started to swell up on 08Apr2021 02:15 P.M. Taking a decongestant when she got home helped that. For a few days she had congestion and brain fog along with general malaise. Treatment received included she took decongestants. The outcome of the events was resolved in Apr2021.  No follow-up attempts are possible. No further information is expected.
Sex: F
Vaccine: COVID19
Symptoms: Body temperature, Chest pain, Influenza, Lymphadenopathy, Pain
Clinical narrative: fever; body ache; flu; swollen lymph node; really bad pain in the chest; This is a spontaneous report from a contactable consumer (patient) received from a Pfizer-sponsored program.  A female patient of an unspecified age received second dose of BNT162B2 (PIZER-BIONTECH COVID-19 VACCINE, lot number and expiration date were not reported), via an unspecified route of administration on 14Apr2021 at single dose for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. The patient received first dose of BNT162B2 (PIZER-BIONTECH COVID-19 VACCINE, lot number and expiration date were not reported), via an unspecified route of administration on 25Mar2021 at single dose for COVID-19 immunization. The patient experienced fever, body ache, flu, swollen lymph node and really bad pain in the chest on an unspecified date in Apr2021. The consumer was asking if these are related to the side effect of the vaccine. The outcome of the events was unknown.  No follow-up attempts are possible; information about lot/batch number cannot be obtained.
Sex: F
Vaccine: COVID19
Symptoms: Pyrexia
Clinical narrative: fever; body ache; flu; swollen lymph node; really bad pain in the chest; This is a spontaneous report from a contactable consumer (patient) received from a Pfizer-sponsored program.  A female patient of an unspecified age received second dose of BNT162B2 (PIZER-BIONTECH COVID-19 VACCINE, lot number and expiration date were not reported), via an unspecified route of administration on 14Apr2021 at single dose for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. The patient received first dose of BNT162B2 (PIZER-BIONTECH COVID-19 VACCINE, lot number and expiration date were not reported), via an unspecified route of administration on 25Mar2021 at single dose for COVID-19 immunization. The patient experienced fever, body ache, flu, swollen lymph node and really bad pain in the chest on an unspecified date in Apr2021. The consumer was asking if these are related to the side effect of the vaccine. The outcome of the events was unknown.  No follow-up attempts are possible; information about lot/batch number cannot be obtained.
Sex: U
Vaccine: COVID19
Symptoms: COVID-19, Drug ineffective, SARS-CoV-2 test
Clinical narrative: tested positive for COVID on 12Apr2021 after coming down with symptoms; tested positive for COVID on 12Apr2021 after coming down with symptoms; This is a spontaneous report from a contactable nurse (patient). A patient of unspecified age and gender received bnt162b2 (Pfizer-BioNTech COVID-19 Vaccine), dose 1 via an unspecified route of administration on Jan2021 (Batch/Lot number was not reported); dose 2 via an unspecified route of administration on Jan2021 (Batch/Lot number was not reported) both as single for covid-19 immunization. The patient's medical history and concomitant medications were not reported. The patient reported receiving both doses of Pfizer COVID-19 vaccine in Jan2021 and the patient tested positive for COVID on 12Apr2021 after coming down with symptoms. The outcome of the events was unknown.   Information about lot/batch number has been requested.; Sender's Comments: Based on the information available, a possible contributory role of the suspect BNT162B2 cannot be excluded for the reported tested positive for COVID  based on the known safety profile.
Age: 59.0
Sex: F
Vaccine: COVID19
Symptoms: Dyspnoea, Feeling abnormal, Lymph node pain, Pain in extremity
Clinical narrative: acute lymphatic response/severe pain in lymph nodes, the ones around her ovaries/severe pain like cysts except both sides were hurting; had trouble catching breath with the pain; arm pain; brain fog/head started feeling foggy and weird; This is a spontaneous report from a contactable consumer reporting for herself. A 59-year-old female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration on 17Mar2021 16:00 (Lot Number: EN5318, Expiry date: 31May2021) on left arm at single dose for COVID-19 immunization. Medical history and concomitant medications were reported as none. Historical Vaccine included flu shots. The patient stated her physician told her she had an acute lymphatic response. She added there was something about 3 am (18Mar2021) because she woke up at 3 am and had severe pain in some of her lymph nodes. In particular, the ones around her ovaries. She added that she was old and her ovaries had not worked in a long time. She had severe pain like cysts except both sides were hurting. She also had trouble catching breath with the pain. This lasted 45 minutes and subsided. The next morning 18Mar2021, when she got up some of her lymph nodes were very panful and there was one even that was a node visible down her throat almost at the base of her neck in the center. She could see it sticking out, it was crazy. It went down in about three days. The pain and the weirdness in all of her other lymph's was about 3 or 4 days. It was an odd response and people told her it was just her body acting like a young person and was going to work. This was the first issue she had with the vaccines. The patient also experienced brain fog after first vaccine on 17Mar2021: within 2 or 3 minutes of having them her head started feeling foggy and weird. It was after the first vaccine, she thought it was psychological but it did not go away and it was not psychological. It was like a weird foggy and like taking sinus medication, no additional details. When it happened with the first vaccine, it did not concern her as much as the first one. It went away after the first vaccine probably late that evening (17Mar2021), around 10:30 pm right when her arm started to hurt. She did not have arm pain that was severe. She added maybe it lasted a day. The next day it hurt but it was not anything bad, it just hurt to touch it and to lift it hurt for a day. Maybe this was for 36-40 hours before the pain went out. The outcome of event "trouble catching breath with the pain" was resolved on 18Mar2021 03:45, outcome of event "brain fog/head started feeling foggy and weird" was resolved on 17Mar2021, outcome of other events were resolved in Mar2021.  No follow-up attempts are needed. No further information is expected.
Sex: M
Vaccine: COVID19
Symptoms: Malaise
Clinical narrative: he was not feeling to well; This is a spontaneous report received from a non-contactable consumer via the Pfizer sponsored program. A male patient of an unspecified age received his first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration on 25Mar2021 (Batch/Lot number was not reported) as SINGLE DOSE for covid-19 immunisation. The patient's medical history and concomitant medications were not reported. The patient said he took the first shot on 25Mar2021. Stated he went in and took a Covid-19 test, and is still waiting for the results. Said today he was not feeling to well (on an unspecified date) and did not elaborate. Outcome of the event was unknown.   No follow-up attempts are possible; information about lot/batch number cannot be obtained.
Age: 58.0
Sex: M
Vaccine: COVID19
Symptoms: Chest pain, Cough, Dyspnoea, Pain
Clinical narrative: chest pain/a little worse; It feel sore every time I move from one side to another/Sore/Hurts when he coughs; It hurts when I cough; Short of breath; This is a spontaneous report from a contactable consumer (Patient). A 57-year-old male patient received first dose of BNT162B2 (Covid shot, PFIZER-BIONTECH COVID-19 VACCINE, Solu-tion for injection, lot number: Solution for injection, lot number: EW0164, NDC number: Unknown, Expiration date: Unknown), via an unspecified route of administration in left arm on 19Apr2021 18:00 (at the age of 58-year-old) as single dose for COVID-19 immunisation (for Covid-19). The patient had no medical history. There was no family history. The patient did not take concomitant medications. There was no previous immunization with the Pfizer vaccine considered as suspect. There were no additional vaccines administered on the same date as the Pfizer vaccine. Patient did not receive prior vaccinations (within 4 weeks). Patient experienced chest pain/a little worse on 19Apr2021, It feel sore every time I move from one side to another/Sore/Hurts when he coughs, It hurts when I cough, short of breath on an unspecified date in Apr2021. Patient stated he have received the first Pfizer shot and experienced chest pain. It feel sore every time he move from one side to another. It hurts when he cough." It was informed to patient that chest pain has not been reported with the vaccine. However, muscle and joint pain has been associated with the vaccine. Please seek medical advice if your symptoms persists or get worst. Chest pain is a symptoms that should not be ignored. Chest pain started late last night and its still sore, it hurts, the same, it was a little worse this morning, but he's laying down not moving around, so it still feels the same, verified as persisting. He did not treat the symptoms in any way. States he said he is going to take some Advil. Any adverse event did not require a visit to emergency room or physician's office. There were no relevant tests. The outcome of event for chest pain/a little worse was not recovered and for other event it was unknown.  No follow-up attempts are needed; information about lot/batch number cannot be obtained.
Sex: F
Vaccine: COVID19
Symptoms: Drug ineffective, SARS-CoV-2 test, SARS-CoV-2 test positive
Clinical narrative: Caller states that she tested positive in between doses and she is scheduled for her second dose on 25Apr2021; Caller states that she tested positive in between doses and she is scheduled for her second dose on 25Apr2021; This is a spontaneous report from a contactable consumer(patient). A 55-years-old female patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; Solution for injection, Lot number was not reported) via an unspecified route of administration as a single dose for COVID-19 immunization on 28Mar2021. The patient's medical history and concomitant medications were not reported. The patient states that she tested positive in between doses and she is scheduled for her second dose on 25apr2021. The patient states that she finished her isolation and asked if she is able to receive the second dose on 25Apr2021. The patient underwent lab tests and procedures which included Covid-19 test: positive- Caller states that she tested positive in between doses.The outcome for the events was Unknown.  Information about the Lot/batch number has been requested.
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Malaise
Clinical narrative: His wife hips and Knees are painful; his wife is not feeling well; This is a spontaneous report received from a Pfizer-sponsored program. A contactable consumer (patient's husband) reported that a female patient of an unspecified age received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; Lot number and expiry date not reported), via an unspecified route of administration on 27Mar2021 at a single dose for COVID-19 immunization. Medical history included ongoing disability (disabled). The patient's concomitant medications were not reported. The reporter stated his wife was scheduled for the second dose on the day of reporting (17Apr2021). She will not make it because she was not feeling well. Her hips and knees were painful. Onset date of the events was not provided. The reporter was asking if it was okay to take the second dose on the next day. The events had not resolved at the time of the report.  No follow-up attempts are possible. Information about lot/batch number cannot be obtained.
Sex: F
Vaccine: COVID19
Symptoms: Headache, Lymphadenopathy, Malaise
Clinical narrative: swollen Lymph nodes; lingering headache; feeling unwell; This is a spontaneous report from a contactable consumer (patient) via medical information team. A female patient of an unspecified age received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE ; lot number and expiration date were not reported), via an unspecified route of administration on an unspecified date at single dose for covid-19 immunization. The patient's medical history and concomitant medications were not reported. The patient experienced swollen lymph nodes, lingering headache and feeling unwell on an unspecified date. She has been experiencing side effects for 5 days and wanted to knowif these symptoms were normal to last this long. The outcome of the events was not recovered.  No follow-up attempts are possible; information about lot/batch number cannot be obtained.
Sex: F
Vaccine: COVID19
Symptoms: Blister, Hypoaesthesia
Clinical narrative: Numb feeling in hands feet and head; Blisters on her body; This is a spontaneous report from a contactable consumer (patient) via a Pfizer sponsored program. A female patient of unspecified age received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration on 03Apr2021 (Batch/Lot number was not reported) as a single dose for COVID-19 immunization.  The patient's medical history and concomitant medications were not reported. The patient received first dose of COVID vaccine on 03Apr2021. The patient experienced numb feeling in hands feet and head she also developed blisters on her body on unspecified dates. The patient is going to urgent care. She is due to receive her second dose on the 24th. She wanted to know if she should get her second dose. Outcome of the events were unknown. The events were assessed as serious (medically significant).   Information on the lot/batch number has been requested.
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, Drug ineffective, SARS-CoV-2 test
Clinical narrative: diagnosed with COVID-19; diagnosed with COVID-19; This is a spontaneous report from a Pfizer-sponsored program. A contactable consumer (patient's son) reported that a female patient (mother) of an unspecified age received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, lot and expiry were not reported), via an unspecified route of administration on 27Mar2021 as single dose for covid-19 immunisation. The patient's medical history and concomitant medications were not reported. The consumer (patient's son) called behalf of his mother (patient) who had the first shot last 27Mar2021 and then in 2021 diagnosed with COVID-19 as well and also now negative with the virus. The patient was given bamlanivimab and took it 5 days ago. The patient was scheduled today for the second shot of COVID-19 Vaccine. The consumer's main concern was to know if the vaccine was safe to take after all. The outcome of the event was recovered in 2021.  Information on the lot/batch number has been requested.
Age: 62.0
Sex: M
Vaccine: COVID19
Symptoms: Limb discomfort, Paraesthesia
Clinical narrative: his arm is "going back and forth with a tingling feeling, like when you cut off blood circulation to a limb, you get the tingling feeling; his arm is "going back and forth with a tingling feeling, like when you cut off blood circulation to a limb, you get the tingling feeling; This is a spontaneous report from a contactable consumer reported for himself. A 62-year-old male patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, Lot number was not reported), via an unspecified route of administration on an unspecified date (at the age of 62-year-old) as a single dose for COVID-19 immunization. The patient medical history and concomitant medications were not reported. Caller reports that his arm was going back and forth with a tingling feeling, like when you cut off blood circulation to a limb, you get the tingling feeling. Reporting that his arm was going through that constantly back and forth even when doing nothing reporting that at one point its good, then the next minute it felt like the circulation was off. The patient was asking if his symptoms are normal and if he should get the second dose with these symptoms. Patients query was responded as he should not get the Pfizer-BioNTech COVID-19 Vaccine if he had a severe allergic reaction after a previous dose of the vaccine or if he had a severe allergic reaction to any ingredient of the vaccine. The decision to receive the second dose for any other reason cannot be made by Pfizer. They referred him to speak to his healthcare provider about the risks of the vaccine compared to the risks of potentially not being fully protected against COVID-19 infection. His healthcare provider would know his health situation and had access to information that could better help inform this decision.The outcome of the event was unknown.   No follow-up attempts are needed; information about lot/batch number cannot be obtained.
Sex: M
Vaccine: COVID19
Symptoms: COVID-19
Clinical narrative: Covid; This is a spontaneous report from a contactable consumer via a Pfizer sponsored program. A male patient of an unspecified age received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, lot number and expiration date were not reported) via an unspecified route of administration on 23Mar2021 as a single dose for COVID-19 immunization. The patient medical history and concomitant medications were not reported. The patient got his 1st dose on 23Mar2021 and then 4 days later got covid. He wanted to know if he should keep the 2nd dose appointment or not. The outcome of the event was unknown.  No follow-up attempts are possible; information about lot/batch number cannot be obtained.
Sex: M
Vaccine: COVID19
Symptoms: Chills, Discomfort, Dizziness, Ear congestion, Fatigue
Clinical narrative: sleepiness; fever; chills; sweating; dizziness; fatigue; brain fog; vertigo; ear congestion; facial pressure/sensation on the right side; he has fluid in both of his ears and diagnosed him with allergic rhinitis; This is a spontaneous report from a contactable consumer (reported for himself).  The 23-year-old male patient received his first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, Lot number: unknown) via an unspecified route of administration as a single dose on 06Apr2021, for Covid-19 immunization. Medical history and concomitant medications were not reported. On an unknown date, after vaccination, the patient experienced sleepiness, fever, chills, sweating, dizziness, fatigue, brain fog, vertigo. He had ear congestion, facial pressure/sensation on the right side, his doctor informed him that he had fluid in both of his ears and diagnosed him with allergic rhinitis. It was stated that most of it had gone but he still had vertigo and dizziness. The outcome of the events of sleepiness, fever, chills, sweating, fatigue, brain fog, ear congestion, facial pressure/sensation on the right side, fluid in both of his ears and diagnosed with allergic rhinitis was not reported, however outcome of the events of was vertigo and dizziness not recovered.   No follow-up attempts are needed. No further information is expected
Sex: M
Vaccine: COVID19
Symptoms: Feeling abnormal, Hyperhidrosis, Pyrexia, Rhinitis allergic, Somnolence
Clinical narrative: sleepiness; fever; chills; sweating; dizziness; fatigue; brain fog; vertigo; ear congestion; facial pressure/sensation on the right side; he has fluid in both of his ears and diagnosed him with allergic rhinitis; This is a spontaneous report from a contactable consumer (reported for himself).  The 23-year-old male patient received his first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, Lot number: unknown) via an unspecified route of administration as a single dose on 06Apr2021, for Covid-19 immunization. Medical history and concomitant medications were not reported. On an unknown date, after vaccination, the patient experienced sleepiness, fever, chills, sweating, dizziness, fatigue, brain fog, vertigo. He had ear congestion, facial pressure/sensation on the right side, his doctor informed him that he had fluid in both of his ears and diagnosed him with allergic rhinitis. It was stated that most of it had gone but he still had vertigo and dizziness. The outcome of the events of sleepiness, fever, chills, sweating, fatigue, brain fog, ear congestion, facial pressure/sensation on the right side, fluid in both of his ears and diagnosed with allergic rhinitis was not reported, however outcome of the events of was vertigo and dizziness not recovered.   No follow-up attempts are needed. No further information is expected
Sex: M
Vaccine: COVID19
Symptoms: Vertigo
Clinical narrative: sleepiness; fever; chills; sweating; dizziness; fatigue; brain fog; vertigo; ear congestion; facial pressure/sensation on the right side; he has fluid in both of his ears and diagnosed him with allergic rhinitis; This is a spontaneous report from a contactable consumer (reported for himself).  The 23-year-old male patient received his first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, Lot number: unknown) via an unspecified route of administration as a single dose on 06Apr2021, for Covid-19 immunization. Medical history and concomitant medications were not reported. On an unknown date, after vaccination, the patient experienced sleepiness, fever, chills, sweating, dizziness, fatigue, brain fog, vertigo. He had ear congestion, facial pressure/sensation on the right side, his doctor informed him that he had fluid in both of his ears and diagnosed him with allergic rhinitis. It was stated that most of it had gone but he still had vertigo and dizziness. The outcome of the events of sleepiness, fever, chills, sweating, fatigue, brain fog, ear congestion, facial pressure/sensation on the right side, fluid in both of his ears and diagnosed with allergic rhinitis was not reported, however outcome of the events of was vertigo and dizziness not recovered.   No follow-up attempts are needed. No further information is expected
Age: 46.0
Sex: F
Vaccine: COVID19
Symptoms: Peripheral swelling, Pruritus
Clinical narrative: swelling of the fingers; itchiness on her palm; This is a spontaneous report received from a contactable physician. A 46-year-old female patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, Lot# unknown), via an unspecified route of administration on 18Apr2021 (at the age of 45-years) as single dose for COVID-19 immunization. Medical history included multiple sclerosis (was a high-risk patient), hypertension, anaphylactic reaction (allergic to Cephalosporins and Steroids) all events are ongoing. Concomitant medication included diovan, immunoglobulins. The patient previously took benadryl for hypersensitivity. Patient took 50 Mg of Benadryl before her first dose. On 18Apr2021 (7-hours of the vaccine), the patient had swelling on her fingers, itchiness on her palm. Patient then took 25mg of Benadryl and took a nap for about 4 hours, when she woke up the swelling and itching were completely gone. The patient received the unspecified treatment for events. The seriousness for event was reported as non-serious by physician. The outcome of the events was recovered.  No follow-up attempts are needed; information about lot/batch number cannot be obtained.
Sex: M
Vaccine: COVID19
Symptoms: Dyspnoea
Clinical narrative: couldn't breathe; This is a spontaneous report from a contactable consumer or other non hcp.     A 54-years-old male patient received bnt162b2 (BNT162B2 solution for injection), dose 2 via an unspecified route of administration on an unspecified date as single dose for covid-19 immunisation. Patient stated he's getting 2nd vaccine shot from Pfizer and couldn't breathe and was freaking out from COVID-19 and almost went to hospital. Patient stated he died twice from a car accident years ago. Patient stated he can't survive without Lyrica but cant afford. Medical history included covid-19 unknown date of First Dose and surgery. The patient's concomitant medications were not reported.  On an unspecified date The patient experienced couldn't breathe.  The outcome of the event was unknown.  Information about lot/batch number has been requested